|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 174.07 GBX | -2.34% |
|
-7.65% | -16.31% |
| 29/04 | EARNINGS AND TRADING: AltynGold reports annual revenue surge | AN |
| 29/04 | Hutchmed Says China Grants Priority Review for Sovleplenib in Autoimmune Hemolytic Anemia | MT |
| Capitalization | 205.27Cr 177.05Cr 162.18Cr 153.25Cr 282.53Cr 20TCr 289.64Cr 1.93TCr 752.66Cr 9.36TCr 770.3Cr 753.88Cr 33TCr | P/E ratio 2026 * |
40.2x | P/E ratio 2027 * | 35.6x |
|---|---|---|---|---|---|
| Enterprise value | 139.43Cr 120.26Cr 110.16Cr 104.09Cr 191.9Cr 13TCr 196.73Cr 1.31TCr 511.24Cr 6.35TCr 523.21Cr 512.06Cr 22TCr | EV / Sales 2026 * |
2.18x | EV / Sales 2027 * | 1.92x |
| Free-Float |
57.69% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: HUTCHMED (China) Limited
| 1 day | -2.34% | ||
| 1 week | -7.65% | ||
| Current month | -10.73% | ||
| 1 month | -20.88% | ||
| 3 months | -20.88% | ||
| 6 months | -20.15% | ||
| Current year | -16.31% |
| 1 week | 174.06 |  | 199.5 |
| 1 month | 174.06 | | 223 |
| Current year | 174.06 | | 239 |
| 1 year | 174.06 | | 292 |
| 3 years | 173.6 | | 353 |
| 5 years | 130 | | 656 |
| 10 years | 130 | | 656 |
| Manager | Title | Age | Since |
|---|---|---|---|
Chig Fung Cheng
CEO | Chief Executive Officer | 59 | 25/08/2025 |
Michael Shi
CTO | Chief Tech/Sci/R&D Officer | 61 | 01/01/2022 |
Karen Atkin
COO | Chief Operating Officer | 60 | 01/01/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Edith Shih
BRD | Director/Board Member | 74 | 01/01/2006 |
Chig Fung Cheng
BRD | Director/Board Member | 59 | 01/01/2011 |
Wei Guo Su
BRD | Director/Board Member | 68 | 27/03/2017 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +3.03% | 0.01% | 33,076 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.34% | -7.65% | -14.25% | -20.15% | 205.27Cr | |
| +3.37% | +3.19% | +35.27% | +130.89% | 91TCr | |
| +0.47% | +2.56% | +50.83% | +44.74% | 55TCr | |
| +2.08% | +2.84% | +15.10% | +47.31% | 38TCr | |
| +1.49% | +0.40% | +24.15% | +11.99% | 33TCr | |
| +0.38% | +1.28% | +33.83% | +15.84% | 29TCr | |
| +0.21% | +2.24% | +28.01% | +30.89% | 29TCr | |
| +1.49% | +1.66% | +47.92% | -1.08% | 28TCr | |
| +0.52% | -3.71% | -36.84% | -51.16% | 20TCr | |
| +1.96% | -1.65% | +19.90% | +48.04% | 18TCr | |
| Average | +0.18% | +0.48% | +20.39% | +25.73% | 34.11TCr | |
| Weighted average by Cap. | +0.33% | +2.13% | +29.78% | +52.00% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 64Cr 55Cr 51Cr 48Cr 88Cr 6.19TCr 90Cr 602.33Cr 234.56Cr 2.92TCr 240.06Cr 234.94Cr 10TCr | 73Cr 63Cr 58Cr 55Cr 101.14Cr 7.11TCr 103.69Cr 691.92Cr 269.46Cr 3.35TCr 275.77Cr 269.89Cr 12TCr |
| Net income | 4.26Cr 3.68Cr 3.37Cr 3.18Cr 5.87Cr 412.59Cr 6.01Cr 40Cr 16Cr 194.23Cr 16Cr 16Cr 678.22Cr | 6.39Cr 5.51Cr 5.05Cr 4.77Cr 8.79Cr 618.42Cr 9.01Cr 60Cr 23Cr 291.13Cr 24Cr 23Cr 1.02TCr |
| Net Debt | -66Cr -57Cr -52Cr -49Cr -91Cr -6.37TCr -93Cr -619.96Cr -241.43Cr -3TCr -247.09Cr -241.82Cr -10TCr | -64Cr -55Cr -51Cr -48Cr -88Cr -6.21TCr -90Cr -603.62Cr -235.07Cr -2.92TCr -240.58Cr -235.45Cr -10TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/26/20 | 174.07 p | -2.34% | 12,912 |
| 19/26/19 | 178.25 p | -2.06% | 23,442 |
| 18/26/18 | 182.00 p | -1.62% | 13,013 |
| 15/26/15 | 185.00 p | -1.33% | 6,716 |
| 14/26/14 | 187.50 p | -0.53% | 6,993 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- HCM Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition